These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 7686561)

  • 41. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).
    Ordi-Ros J; Pérez-Pemán P; Monasterio J
    Haemostasis; 1994; 24(3):165-74. PubMed ID: 7988946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of experimental systemic lupus erythematosus in mice by immunization with a monoclonal anti-La autoantibody.
    Fricke H; Offen D; Mendlovic S; Shoenfeld Y; Bakimer R; Sperling J; Mozes E
    Int Immunol; 1990; 2(3):225-30. PubMed ID: 2088487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
    Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
    Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance].
    Wisløff F; Sletnes KE; Schjetlein R
    Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2269-72. PubMed ID: 8362396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution of two common idiotypes of anticardiolipin antibodies in sera of patients with primary antiphospholipid syndrome, systemic lupus erythematosus and monoclonal gammopathies.
    Krause I; Cohen J; Blank M; Bakimer R; Cartman A; Hohmann A; Valesini G; Asherson RA; Khamashta MA; Hughes GR
    Lupus; 1992 Feb; 1(2):91-6. PubMed ID: 1301969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.
    Blank M; Waisman A; Mozes E; Koike T; Shoenfeld Y
    Int Immunol; 1999 Dec; 11(12):1917-26. PubMed ID: 10590257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations.
    Abu-Shakra M; Gladman DD; Urowitz MB; Farewell V
    Am J Med; 1995 Dec; 99(6):624-8. PubMed ID: 7503085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
    Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
    Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of a human IgM monoclonal anticardiolipin antibody on pregnancy in a transgenic mouse model.
    Mason AN; Mageed RA; Mackworth-Young CG
    Lupus; 2001; 10(4):289-94. PubMed ID: 11341106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Assay of anticardiolipin antibodies and its clinical significance].
    Okada J; Nomura M
    Rinsho Byori; 1993 Aug; 41(8):859-65. PubMed ID: 8371501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype.
    Tincani A; Balestrieri G; Allegri F; Cattaneo R; Fornasieri A; Li M; Sinico A; D'Amico G
    Clin Exp Rheumatol; 1993; 11(2):129-34. PubMed ID: 7685255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
    Campos LM; Kiss MH; D'Amico EA; Silva CA
    Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal anticardiolipin autoantibodies established from the (New Zealand white x BXSB)F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein.
    Mizutani H; Kurata Y; Kosugi S; Shiraga M; Kashiwagi H; Tomiyama Y; Kanakura Y; Good RA; Matsuzawa Y
    Arthritis Rheum; 1995 Oct; 38(10):1382-8. PubMed ID: 7575688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.